| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 4 |
| 1 | CYCLOPHOSPHAMIDE | 3 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 4 | CYTARABINE | 3 |
| 5 | DEXAMETHASONE | 2 |
| 6 | DEXAMETHASONE 1.5 MG | 2 |
| 7 | DOXORUBICIN | 2 |
| 8 | LENALIDOMIDE | 2 |
| 9 | PREDNISONE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INOTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 1 | CLADRIBINE | 1 | 0.0001 |
| 2 | PEGASPARGASE | 1 | 0.0001 |
| 3 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 4 | MERCAPTOPURINE | 1 | 0.0001 |
| 5 | CYTARABINE | 3 | 0.0000 |
| 6 | IFOSFAMIDE FOR INJECTION | 1 | 0.0000 |
| 7 | AZACITIDINE | 1 | 0.0000 |
| 8 | FLUDARABINE PHOSPHATE | 1 | 0.0000 |
| 9 | DOXORUBICIN | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 1 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 4 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 8 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |